Tafamidis-Treated Cardiac Amyloidosis Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Tafamidis-Treated Cardiac Amyloidosis
Tafamidis-treated cardiac amyloidosis, specifically transthyretin amyloid cardiomyopathy (ATTR-CM), is a serious heart condition where abnormal protein deposits stiffen the heart. Tafamidis is a vital medication slowing disease progression. TheDrugClub helps patients afford this essential treatment, making managing ATTR-CM more accessible through discounted prescription prices.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.